Subcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients

Ustundag, SedatDOGAN, EkremDURANAY, MuratKazancioglu, RÜMEYZACELIK, VedatUNSAL, AbdulkadirALTINTEPE, LutfullahDursun, BeldaAKBAS, ErtugrulOZDENER, FatihYildiz, Alaattin2019-10-052019-10-052016-05-01Ustundag S., DOGAN E., DURANAY M., Kazancioglu R., CELIK V., UNSAL A., ALTINTEPE L., Dursun B., AKBAS E., OZDENER F., et al., -Subcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients-, BALKAN MEDICAL JOURNAL, cilt.33, ss.322-330, 2016https://hdl.handle.net/20.500.12645/1826Background: We investigated the efficacy, safety and tolerability of once-monthly administration of C.E.R.A. in erythropoiesis stimulating agents (ESAs) naive predialysis patients with CKD for anemia treatmenteninfo:eu-repo/semantics/openAccessSubcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis PatientsArticleWOS:0003793320000118497161208910.5152/balkanmedj.2016.141173